Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease

Abstract

Amyotrophic lateral sclerosis (ALS) is a multifactorial disease, characterized by a progressive loss of motor neurons that eventually leads to paralysis and death. The current ALS-approved drugs modestly change the clinical course of the disease. The mechanism by which motor neurons progressively degenerate remains unclear but entails a non-cell autonomous process. Astrocytes impaired biological functionality were implicated in multiple neurodegenerative diseases, including ALS, frontotemporal dementia (FTD), Parkinson's disease (PD), and Alzheimer disease (AD). In ALS disease patients, A1 reactive astrocytes were found to play a key role in the pathology of ALS disease and death of motor neurons, via loss or gain of function or acquired toxicity. The contribution of astrocytes to the maintenance of motor neurons by diverse mechanisms makes them a promising therapeutic candidate for the treatment of ALS. Therapeutic approaches targeting at modulating the function of endogenous astrocytes or replacing lost functionality by transplantation of healthy astrocytes, may contribute to the development of therapies which might slow down or even halt the progression ALS diseases. The proposed mechanisms by which astrocytes can potentially ameliorate ALS progression and the status of ALS clinical studies involving astrocytes are discussed.

Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

“…To explore the cellular and molecular bases underlying this dual effect of the CB 2 receptor represents one important objective to be investigated in the coming years. This will possibly reinforce the dual role that glial cells appear to exert in ALS in the control of motor neuron integrity, which includes both therapeutic effects and also contribution in the pathogenic events (see Izrael et al, 2020, for a recent review).…”

She Doesn’t Even Go Here: The Role of Inflammatory Astrocytes in CNS Disorders

“…Amyloid Lateral Sclerosis Intrathecal transplantation of human-grade astrocytes (Izrael et al, 2020).…”

Space-occupying brain lesions, trauma-related tau astrogliopathy, and ARTAG: a report of two cases and a literature review

“…Astrocytes also help remove cellular waste via glymphatic flow [18]. Given the many necessary functions of astrocytes in CNS physiology, astrocytic failure may contribute to synaptic dysfunction, neuronal loss, and neurodegeneration through a number of biologic mechanisms [19][20][21].…”